Commission Implementing Regulation (EU) 2023/948 of 12 May 2023 authorising the placing on the market of 6′-Sialyllactose sodium salt produced by derivative strains of Escherichia coli BL21(DE3) as a novel food and amending Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)
Article 1
In force · version of Jun 4, 2023
1. 6′-Sialyllactose sodium salt produced with derivative strains of Escherichia coli BL21(DE3) is authorised to be placed on the market within the Union. 6′-Sialyllactose sodium salt produced with derivative strains of Escherichia coli BL21(DE3) shall be included in the Union list of novel foods set out in Implementing Regulation (EU) 2017/2470.
2. The Annex to Implementing Regulation (EU) 2017/2470 is amended in accordance with the Annex to this Regulation.